RE: First ever Heart AI algo approved by FDA, industry news13 Apr 2026 09:38
Read draft’s article.
FDA Clears First AI Algorithm to Diagnose Cardiac Amyloidosis
Then think of 4th December RNS
GENinCode Plc (AIM: GENI), the Oxford based predictive genetics company focused on the prevention of cardiovascular disease ("CVD") and risk assessment of ovarian cancer, announces today a collaboration with Thermo Fisher Scientific to sell, distribute and manufacture the CARDIO inCode-Score® Polygenic Risk Score ("PRS") test for the prediction and prevention of coronary heart disease ("CHD" or "heart disease").
Then think why did BoD chuck so much in? or why was there a request for extra placing after the first batch?
Answers on a postcard, but the correct answer is moon
3p plus coming